Liangzheng You

Dr. Liangzheng You


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 May 2025 in Frontiers in Endocrinology
Verified
Journal Article
Open access
PDF file
CJChenyang Ji
Chenyang Ji
TJTong Jiang
Tong Jiang
LLLuolin Liu
Luolin Liu
JZJiale Zhang
Jiale Zhang
LYLiangzheng You
Liangzheng You
Prediabetes represents an early stage of glucose metabolism disorder with significant public health implications. Although traditional lifestyle interventions have demonstrated some efficacy in preventing the progression to type 2 diabetes, their limitations—such as lack of personalization, restricted real-time monitoring, and delayed intervention—are increasingly apparent. This article systematically explores the potential applications of continuous glucose monitoring (CGM) technology combined with artificial intelligence (AI) in the management of prediabetes. CGM provides real-time and dynamic glucose monitoring, addressing the shortcomings of conventional methods, while AI enhances the clinical utility of CGM data through deep learning and advanced data analysis. This review examines the advantages of integrating CGM and AI from three perspectives: precise diagnosis, personalized intervention, and decision support. Additionally, it highlights the unique roles of this integration in remote monitoring, shared decision-making, and patient empowerment. The article further discusses challenges related to data management, algorithm optimization, ethical considerations, and future directions for this technological integration. It proposes fostering multidisciplinary collaboration to promote the application of these innovations in diabetes management, aiming to deliver a more precise and efficient health management model for individuals with prediabetes.

1 July 2025 in Journal of Inflammation Research
Verified
Journal Article
Open access
PDF file
JFJunhao Fang
Junhao Fang
YWYanlin Wu
Yanlin Wu
HWHan Wang
Han Wang
JZJiale Zhang
Jiale Zhang
LYLiangzheng You
Liangzheng You
Diabetic Cardiomyopathy (DCM) is a common cardiovascular complication in patients with diabetes. In recent years, the association between oral health and diabetic heart disease has gained increasing attention. This perspective reviews the potential mechanisms of oral diseases in diabetic heart disease, oral indicators for early screening of diabetic heart disease, and proposes future research directions. The potential mechanisms of oral diseases in diabetic heart disease primarily involve abnormal activation of inflammatory responses, dysregulation of the oral microbiome, and immune system disorders. In the context of early screening for diabetic heart disease, oral health indices, salivary biomarkers, and the oral microbiome serve as critical oral indicators with significant clinical value for early diagnosis. Future research should promote interdisciplinary diagnosis and collaboration, develop non-invasive early screening technologies, integrate multimodal and multi-omics oral data, leverage large-scale multicenter clinical data to comprehensively evaluate the association between oral health indicators and diabetic cardiomyopathy, and simultaneously train and validate precise artificial intelligence models. This perspective integrates existing research findings on the role of oral health in diabetic heart disease, highlights current research limitations, and emphasizes the need for further studies to clarify causal relationships and facilitate widespread clinical application.

6 August 2024 in Scientific Reports
Verified
Journal Article
Open access
PDF file
KZKaige Zhang
Kaige Zhang
XZXiaoying Zhong
Xiaoying Zhong
XFXiaodan Fan
Xiaodan Fan
DYDongdong Yu
Dongdong Yu
ZCZhuo Chen
Zhuo Chen
HSHongcai Shang
Hongcai Shang
To explore the clinical characteristics of patients infected with SARS-CoV-2 nationwide, especially the effect factors of asymptomatic infection and disappearance of clinical symptoms. A total of 66,448 COVID-19 patients in China who have been diagnosed by nucleic acid test or rapid antigen test were surveyed online (December 24, 2022 to January 16, 2023). Our cross-sectional study used descriptive analyses and binary Logistics regression model to assess the correlation between the clinical characteristics and relative factors, including age, gender, pre-existing conditions, reinfection, vaccination and treatment. A total of 64,515 valid questionnaires were collected. Among included participants, 5969 of which were asymptomatic. The symptoms were mainly upper respiratory symptoms, including dry and itchy throat (64.16%), sore throat (59.95%), hoarseness (57.90%), nasal congestion (53.39%). In binary Logistics regression model, we found that male, no pre-existing conditions, reinfection and vaccination have positive correlations with the appearance of asymptomatic COVID-19 patients. In Cox proportional-hazards regression model, considering all clinical symptoms disappeared in 14 days as outcome, we found that ≤ 60 years old, male, no pre-existing conditions, vaccination and adopted treatment have positive correlations with rapid amelioration of clinical symptoms in COVID-19 patients. The clinical symptoms of the participants were mainly upper respiratory symptoms which were according with the infection of Omicron variant. Factors including age, gender, pre-existing conditions and reinfection could influence the clinical characteristics and prognosis of COVID-19 patients. Importantly, vaccination has positive significance for the prevention and treatment of COVID-19. Lastly, the use of Chinese medicine maybe beneficial to COVID-19 patients, however, reasonable guidance is necessary.

3 July 2024 in Chinese Journal of Integrative Medicine
Verified
Journal Article
Closed access
PDF file
QXQian-Qian Xu
Qian-Qian Xu
DYDong-Dong Yu
Dong-Dong Yu
XFXiao-Dan Fan
Xiao-Dan Fan
HCHe-Rong Cui
He-Rong Cui
QDQian-Qian Dai
Qian-Qian Dai
HSHong-Cai Shang
Hong-Cai Shang

5 January 2026 in Life Sciences
Verified
Journal Article
Closed access
XLXiao Li
Xiao Li
QZQingyue Zeng
Qingyue Zeng
XZXiaoyu Zhang
Xiaoyu Zhang
SWShuangqiu Wang
Shuangqiu Wang
TJTong Jiang
Tong Jiang
HSHongcai Shang
Hongcai Shang

14 January 2026 in World Journal of Gastroenterology
Verified
Journal Article
Open access
JZJia-Le Zhang
Jia-Le Zhang
LYLiangzheng You
Liangzheng You
This editorial examines the emerging potential of traditional Chinese medicine (TCM) in enhancing postoperative recovery following gastroenteroscopy, highlighted by a 2025 randomized controlled trial by Hong et al . The study, involving 120 patients, demonstrates that meridian flow injection (MFI) combined with transcutaneous electrical acupoint stimulation (TEAS) significantly improves gastrointestinal (GI) function, evidenced by a reduced time to first defecation (3.20 ± 1.04 days vs 3.98 ± 1.27 days, P < 0.001), lowers stress biomarkers (e.g. , reduced cortisol and norepinephrine), and enhances clinical efficacy (93.33% vs 75.00%, P = 0.006). Leveraging TCM’s five-element theory and Ziwu Liuzhu timing, the intervention targets key acupoints such as Zusanli (ST36) with a herbal paste comprising Qingpi, Houpu, and rhubarb, delivered transdermally to optimize bioavailability. This approach harmonizes ancient TCM principles with contemporary evidence-based practice, offering a holistic strategy to address postoperative nausea, delayed motility, and patient discomfort. Currently, integrative methods like MFI-TEAS are gaining traction, supported by recent meta-analyses that affirm TEAS’s efficacy in accelerating GI recovery across surgical contexts, including shortened times to first exhaust and defecation. This reflects a growing recognition of TCM’s role in perioperative care amidst rising global endoscopy demands. Looking forward, future research should prioritize multicenter, double-blinded trials to enhance generalizability, adhere to standardized reporting frameworks such as CONSORT and STRICTA, and employ advanced tools like multi-omics and functional magnetic resonance imaging to elucidate mechanistic pathways, including gut-brain axis modulation and microbiota-immune interactions. Such developments promise to refine these interventions, fostering a seamless integration of TCM with Western medicine and delivering tailored, patient-centered solutions to improve postoperative outcomes worldwide.